Drug Delivery Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Drug Delivery stocks.

Drug Delivery Stocks Recent News

Date Stock Title
Jan 31 BDX BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year
Jan 31 HTGC Hercules Capital (NYSE:HTGC) investors are sitting on a loss of 10% if they invested a year ago
Jan 30 MDT Medtronic recalls ~23K Mahurkar hemodialysis catheters
Jan 30 WST Dividend Kings and Aristocrats List: 50 Biggest Stocks
Jan 30 BDX BD (BDX) Gears Up for Q1 Earnings: What's in the Offing?
Jan 30 BDX Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
Jan 28 MDT The use of artificial intelligence in medical devices and drug development
Jan 27 BDX McKesson (MCK) to Report Q3 Earnings: Is a Beat in the Cards?
Jan 27 TTNP Theriva Biologics, Research Frontiers And 1 Other Penny Stock Insiders Are Aggressively Buying
Jan 26 MDT Medtronic (MDT) Presents at the J.P. Morgan 41st Annual Healthcare Conference - Slideshow
Jan 26 BDX Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Should You Buy?
Jan 26 MDT Students Use Robotics Skills To Increase Inclusion, Diversity, and Equity
Jan 26 MDT Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation
Jan 25 MDT Medtronic (MDT) Gains As Market Dips: What You Should Know
Jan 25 HTGC Hercules Capital: 2 Top Reasons To Buy This 10.1%-Yielding BDC
Jan 25 MDT These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Jan 25 BDX BD Publishes 2022 Cybersecurity Annual Report
Jan 24 BDX Becton, Dickinson declares $0.91 dividend
Jan 24 BDX BD Board Declares Dividend
Jan 24 BDX Why Becton Dickinson (BDX) Could Beat Earnings Estimates Again
Drug Delivery

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms. Some of the common routes of administration include the enteral (gastrointestinal tract), parenteral (via injections), inhalation, transdermal, topical and oral routes. . Many medications such as peptide and protein, antibody, vaccine and gene based drugs, in general may not be delivered using these routes because they might be susceptible to enzymatic degradation or can not be absorbed into the systemic circulation efficiently due to molecular size and charge issues to be therapeutically effective. For this reason many protein and peptide drugs have to be delivered by injection or a nanoneedle array.
For example, many immunizations are based on the delivery of protein drugs and are often done by injection.
Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues), sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation, and methods to increase survival of peroral agents which must pass through the stomach's acidic environment. In order to achieve efficient targeted delivery, the designed system must avoid the host's defense mechanisms and circulate to its intended site of action. Types of sustained release formulations include liposomes, drug loaded biodegradable microspheres and drug polymer conjugates. Survival of agents as they pass through the stomach typically is an issue for agents which cannot be encased in a solid tablet; one research area has been around the utilization of lipid isolates from the acid-resistant archaea Sulfolobus islandicus, which confers on the order of 10% survival of liposome-encapsulated agents.

Browse All Tags